Patterson Sandra 4
4 · GILEAD SCIENCES, INC. · Filed Dec 11, 2024
Insider Transaction Report
Form 4
Patterson Sandra
SVP, Controllership
Transactions
- Exercise/Conversion
Restricted Stock Unit
2024-12-10−901→ 12,282 total→ Common Stock (901 underlying) - Exercise/Conversion
Common Stock
2024-12-10+901→ 37,486 total - Tax Payment
Common Stock
2024-12-10$92.34/sh−408$37,675→ 37,078 total
Footnotes (2)
- [F1]Each restricted stock unit represents the contingent right to receive one share of Gilead Sciences, Inc.'s common stock.
- [F2]The restricted stock units have a four year vesting schedule. 25% vest on the first anniversary of the date of grant. The balance will vest 6.25% quarterly thereafter until fully vested.